USPTO serial 79394301
NEC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 28, 2025
- Examiner
- GUARNIERI, GRACE K
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Nippon Denki Kabushiki Kaisha (NEC Corporation)
JP
Other trademarks owned by Nippon Denki Kabushiki Kaisha (NEC Corporation)
Nippon Denki Kabushiki Kaisha (NEC Corporation)
JP
Other trademarks owned by Nippon Denki Kabushiki Kaisha (NEC Corporation)
Nippon Denki Kabushiki Kaisha (NEC Corporation)
JP
Other trademarks owned by Nippon Denki Kabushiki Kaisha (NEC Corporation)
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard Y. Kim
Richard Y. Kim Snell & Wilmer L.L.P.One East Washington Street, Suite 2700Phoenix, AZ 85004-2556United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines; vaccines preparations; vaccine preparations for the prevention and treatment of cancer, infection and auto immune disease; pharmaceuticals and pharmaceutical preparations for human use for the prevention and treatment of cancer, infection and auto immune disease; companion diagnostic agents for medical use; pharmaceutical preparations for the treatment and prevention of cancer, infection and auto immune disease namely cellular therapeutics; pharmaceutical preparations for the treatment of cell related viral diseases; reagent paper for medical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes, namely, drinks for babies; food for babies; dietary supplements for animals | ACTIVE | — |
| 009 | Downloadable and recorded computer software for use in analyzing and identifying genome information; Downloadable and recorded computer software for medical process management of individual personalized treatment; Downloadable and recorded computer software for patient stratification; Downloadable and recorded operating system computer software for use with companion diagnostic medical devices; Downloadable and recorded computer software platforms for use in medical data management; Downloadable and recorded computer operating programs; Downloadable and recorded computer operating system software; computers and computer hardware; computer network servers; computer peripheral apparatus; Downloadable and recorded computer software and downloadable application software for collecting and storage of patient data and medical information; Data processing equipment in the nature of data processing systems for collecting and storage of patient data and medical information | ACTIVE | — |
| 035 | Collection of information into computer databases in the field of genetic and genomic information and life science; Collection of genome information into computer databases for medical purposes; collection of information into computer databases in the field of medical information | ACTIVE | — |
| 042 | Research and development of vaccines and medicines; scientific research in the nature of conducting clinical trials for others; research and development of medicines in the nature of companion diagnostic agent; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; scientific research in the field of genetics; medical research; design and development of computer hardware and software for use in companion diagnostic; designing of machines, apparatus, instruments and their parts or systems composed of such machines, apparatus and instruments; technology advisory and consultancy services relating to the design and development of computer hardware; computer programming; medical and scientific research in the field of gene analysis; Scientific and technological services, namely, genome research, testing, analysis, and evaluation of genome samples for scientific research purposes and providing information thereof; Scientific and technological services, namely, investigation and analysis of genome samples for scientific research purposes; providing on-line non downloadable software for use in analyzing and identifying genome information; providing on-line non downloadable software for medical process management of individual personalized treatment; providing on-line non downloadable software for patient stratification; providing on-line non downloadable operating system software for use with companion diagnostic medical devices; platform as a service (PaaS) featuring computer software platforms for use in medical data management; design and development of computer software for medical data analysis and management; rental of computers; providing temporary use of on-line non- downloadable cloud computing software and computer programs on data networks for medical data management; software as a service (SaaS) featuring software for medical data management; research and development in the field of cellular therapeutics; structural and functional analysis of genomes; Providing information about medical research, namely, genome information analysis; Scientific and technological services, namely, providing scientific analysis in the field of genomic data; providing on-line non downloadable software for use in collecting, analyzing, evaluating, interpreting and predicting genetic and genomic information; providing science information in the fields of genetic and genomic information and life science; Biological research in the nature of analysis of biological samples | ACTIVE | — |
| 044 | Providing medical information related to the preservation of genome information for medical purposes; Providing medical information in the nature of collected genome information; providing medical information in the field of cellular therapeutics; medical diagnostic testing and monitoring services in the field of cellular therapeutics, namely, cell therapy; medical assistance services in the nature of information about genetic testing and medical information provided to remote medical professionals via the Internet and global computer networks through the use of genome sequence information, medical images, diagnostic test results, and data storage and retrieval systems; medical services relating to the collection, processing and preservation of biological samples; collection and preservation of biological samples, namely, human cells; medical laboratory services for the analysis of biological samples; medical analysis services for diagnostic and treatment provided by medical laboratories relating to cell, tissue, gene expression, gene sequence, genome annotation, transcriptome characteristic analysis, genome mapping; provision of medical information; physical examination services; providing an internet website for medical professionals and medical patients featuring medical information and medical data which users process, exchange and access in real time | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nippon Denki Kabushiki Kaisha (NEC Corporation)
- Other trademarks owned by Nippon Denki Kabushiki Kaisha (NEC Corporation)
- Other trademarks owned by Nippon Denki Kabushiki Kaisha (NEC Corporation)
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NEC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 24, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 24, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 16, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 16, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 29, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 8, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 8, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 11, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 23, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 27, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 10, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 25, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |